Page last updated: 2024-08-25

methotrexate and End Stage Liver Disease

methotrexate has been researched along with End Stage Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aithal, GP; Dawwas, MF	1

Other Studies

1 other study(ies) available for methotrexate and End Stage Liver Disease

Article	Year
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome. Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:8 Topics: Aged; Body Mass Index; Cholangitis, Sclerosing; Diabetes Mellitus; End Stage Liver Disease; Female; Humans; Immunosuppressive Agents; Liver Diseases, Alcoholic; Liver Transplantation; Logistic Models; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Odds Ratio; Risk Factors; United States	2014

Article

Year

End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome.

Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:8

Topics: Aged; Body Mass Index; Cholangitis, Sclerosing; Diabetes Mellitus; End Stage Liver Disease; Female; Humans; Immunosuppressive Agents; Liver Diseases, Alcoholic; Liver Transplantation; Logistic Models; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Odds Ratio; Risk Factors; United States

2014